CANCER TARGETED GENE PANEL, COLON/COLORECTAL
This panel studies mismatch repair proteins in Hereditary Nonpolyposis Colorectal cancer. These biomarkers are used for better understanding of the kinetics and effectiveness of a drug. It detects early signals of efficacy for rapidly evaluating the impact of potential disease-modifying therapies.
Parameter(s) covered : 5
Report Frequency: Sample Tue by 9 am; Report 10 Working days
Special Instruction: Tissue block must contain at least 10% tumor tissue. Physician prescription is mandatory.
Price : ₹ 16200.00
Parameters
- MLHI (MutL Homolog 1)
- MSH2 (MutS Homolog 2)
- MSH6 ( MutS Homolog 6)
- NGS COLON PANEL
- PMS2 (Post meiotic segregation)